$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Option Exercise | M | 0.00 | 5,667 | 0 | 17,000 | |
Apr 19 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Payment of Exercise | F | 41.03 | 1,960 | 80,419 | 4,199 | 6.2 K to 4.2 K (-31.82 %) |
Apr 19 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Buy | M | 0.00 | 5,667 | 0 | 6,159 | 492 to 6.2 K (+1,151.83 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Buy | J | 44.54 | 460 | 20,488 | 11,295 | 10.8 K to 11.3 K (+4.25 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Buy | J | 44.54 | 197 | 8,774 | 26,699 | 26.5 K to 26.7 K (+0.74 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | J | 44.54 | 116 | 5,167 | 43,587 | 43.5 K to 43.6 K (+0.27 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Buy | J | 44.54 | 414 | 18,440 | 41,920 | 41.5 K to 41.9 K (+1.00 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Buy | J | 44.54 | 492 | 21,914 | 492 | 0 to 492 |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | J | 44.54 | 112 | 4,988 | 42,620 | 42.5 K to 42.6 K (+0.26 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Sell | S | 54.28 | 236 | 12,809 | 50,114 | 50.4 K to 50.1 K (-0.47 %) |
Mar 02 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | J | 44.54 | 247 | 11,001 | 50,350 | 50.1 K to 50.4 K (+0.49 %) |
Feb 01 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Payment of Exercise | F | 60.69 | 1,306 | 79,261 | 50,103 | 51.4 K to 50.1 K (-2.54 %) |
Feb 01 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Grant | A | 0.00 | 2,634 | 0 | 51,409 | 48.8 K to 51.4 K (+5.40 %) |
Jan 28 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 63.74 | 28,333 | 1,805,812 | 2,021 | 30.4 K to 2 K (-93.34 %) |
Jan 27 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Sell | S | 63.50 | 5,324 | 338,074 | 26,502 | 31.8 K to 26.5 K (-16.73 %) |
Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 61.68 | 40,000 | 2,467,000 | 494,391 | 534.4 K to 494.4 K (-7.49 %) |
Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 61.65 | 21,042 | 1,297,239 | 534,391 | 555.4 K to 534.4 K (-3.79 %) |
Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 60.53 | 13,958 | 844,878 | 555,433 | 569.4 K to 555.4 K (-2.45 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 0.00 | 4,371 | 0 | 7,801 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 0.00 | 47,257 | 0 | 87,885 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Payment of Exercise | F | 61.28 | 1,434 | 87,876 | 3,111 | 4.5 K to 3.1 K (-31.55 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 0.00 | 4,371 | 0 | 4,545 | 174 to 4.5 K (+2,512.07 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Payment of Exercise | F | 61.28 | 18,924 | 1,159,663 | 30,354 | 49.3 K to 30.4 K (-38.40 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 0.00 | 47,257 | 0 | 49,278 | 2 K to 49.3 K (+2,338.30 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Option Exercise | A | 0.00 | 24,228 | 0 | 24,228 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 0.00 | 15,520 | 0 | 29,641 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | A | 0.00 | 20,822 | 0 | 20,822 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Payment of Exercise | F | 61.28 | 5,488 | 336,305 | 42,508 | 48 K to 42.5 K (-11.43 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 0.00 | 15,520 | 0 | 47,996 | 32.5 K to 48 K (+47.79 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Option Exercise | M | 0.00 | 17,598 | 0 | 34,246 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Option Exercise | A | 0.00 | 22,714 | 0 | 22,714 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Payment of Exercise | F | 61.28 | 6,398 | 392,069 | 41,506 | 47.9 K to 41.5 K (-13.36 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Buy | M | 0.00 | 17,598 | 0 | 47,904 | 30.3 K to 47.9 K (+58.07 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 0.00 | 17,151 | 0 | 34,199 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | A | 0.00 | 27,129 | 0 | 27,129 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Payment of Exercise | F | 61.28 | 6,175 | 378,404 | 43,471 | 49.6 K to 43.5 K (-12.44 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 0.00 | 17,151 | 0 | 49,646 | 32.5 K to 49.6 K (+52.78 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | M | 0.00 | 34,823 | 0 | 77,243 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 0.00 | 77,447 | 0 | 77,447 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 0.00 | 66,610 | 0 | 66,610 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Payment of Exercise | F | 61.28 | 14,927 | 914,727 | 48,775 | 63.7 K to 48.8 K (-23.43 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | M | 0.00 | 34,823 | 0 | 63,702 | 28.9 K to 63.7 K (+120.58 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Option Exercise | M | 0.00 | 16,504 | 0 | 32,253 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Option Exercise | A | 0.00 | 25,868 | 0 | 25,868 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Payment of Exercise | F | 61.28 | 5,856 | 358,856 | 31,826 | 37.7 K to 31.8 K (-15.54 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Buy | M | 0.00 | 16,504 | 0 | 37,682 | 21.2 K to 37.7 K (+77.93 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 10,655 | 0 | 5,754 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Payment of Exercise | F | 61.28 | 2,741 | 167,968 | 65,378 | 68.1 K to 65.4 K (-4.02 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 10,655 | 0 | 68,119 | 57.5 K to 68.1 K (+18.54 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Option Exercise | M | 0.00 | 7,503 | 0 | 15,256 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Option Exercise | A | 0.00 | 15,753 | 0 | 15,753 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Payment of Exercise | F | 61.28 | 2,718 | 166,559 | 6,903 | 9.6 K to 6.9 K (-28.25 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Buy | M | 0.00 | 7,503 | 0 | 9,621 | 2.1 K to 9.6 K (+354.25 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Option Exercise | M | 0.00 | 8,944 | 0 | 16,944 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Option Exercise | A | 0.00 | 23,976 | 0 | 23,976 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Payment of Exercise | F | 61.28 | 3,216 | 197,076 | 10,835 | 14.1 K to 10.8 K (-22.89 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Buy | M | 0.00 | 8,944 | 0 | 14,051 | 5.1 K to 14.1 K (+175.13 %) |
Jan 15 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Sell | S | 59.50 | 141 | 8,390 | 30,306 | 30.4 K to 30.3 K (-0.46 %) |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Option Exercise | A | 56.78 | 53,945 | 3,062,997 | 53,945 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Sell | S | 55.99 | 195 | 10,918 | 5,107 | 5.3 K to 5.1 K (-3.68 %) |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | A | 56.78 | 12,000 | 681,360 | 12,000 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Option Exercise | A | 56.78 | 58,203 | 3,304,766 | 58,203 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 56.78 | 149,872 | 8,509,732 | 149,872 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | A | 56.78 | 61,041 | 3,465,908 | 61,041 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Option Exercise | A | 56.78 | 51,107 | 2,901,855 | 51,107 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Option Exercise | A | 56.78 | 54,513 | 3,095,248 | 54,513 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | A | 56.78 | 46,850 | 2,660,143 | 46,850 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Option Exercise | A | 56.78 | 35,444 | 2,012,510 | 35,444 | |
Dec 28 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 60.00 | 10,000 | 600,000 | 57,464 | 67.5 K to 57.5 K (-14.82 %) |
Dec 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.50 | 1,407 | 71,054 | 174 | 1.6 K to 174 (-88.99 %) |
Dec 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 49.78 | 39,000 | 1,941,225 | 600,391 | 639.4 K to 600.4 K (-6.10 %) |
Dec 04 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 39.87 | 7,053 | 281,203 | 7,947 | |
Dec 04 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Sell | S | 51.32 | 7,053 | 361,960 | 32,476 | 39.5 K to 32.5 K (-17.84 %) |
Dec 04 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 39.87 | 7,053 | 281,203 | 39,529 | 32.5 K to 39.5 K (+21.72 %) |
Dec 04 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | M | 39.87 | 21,160 | 843,649 | 23,840 | |
Dec 04 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Sell | S | 51.32 | 21,160 | 1,085,931 | 28,879 | 50 K to 28.9 K (-42.29 %) |
Dec 04 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | M | 39.87 | 21,160 | 843,649 | 50,039 | 28.9 K to 50 K (+73.27 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Option Exercise | M | 39.87 | 11,920 | 475,250 | 0 | |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Sell | S | 50.05 | 11,920 | 596,596 | 30,447 | 42.4 K to 30.4 K (-28.14 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Buy | M | 39.87 | 11,920 | 475,250 | 42,367 | 30.4 K to 42.4 K (+39.15 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 21,680 | 864,382 | 0 | |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.05 | 21,680 | 1,085,084 | 32,495 | 54.2 K to 32.5 K (-40.02 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 21,680 | 864,382 | 54,175 | 32.5 K to 54.2 K (+66.72 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 12,990 | 517,911 | 0 | |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.05 | 12,990 | 650,150 | 2,021 | 15 K to 2 K (-86.54 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 12,990 | 517,911 | 15,011 | 2 K to 15 K (+642.75 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 39.87 | 3,590 | 143,133 | 0 | |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 50.05 | 3,590 | 179,680 | 67,464 | 71.1 K to 67.5 K (-5.05 %) |
Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 39.87 | 3,590 | 143,133 | 71,054 | 67.5 K to 71.1 K (+5.32 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 2,590 | 103,263 | 12,990 | |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 11,600 | 462,492 | 15,580 | |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 500 | 19,935 | 0 | |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.83 | 2,590 | 131,650 | 2,021 | 4.6 K to 2 K (-56.17 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 2,590 | 103,263 | 4,611 | 2 K to 4.6 K (+128.15 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.11 | 11,600 | 581,276 | 2,021 | 13.6 K to 2 K (-85.16 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 11,600 | 462,492 | 13,621 | 2 K to 13.6 K (+573.97 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.00 | 500 | 25,000 | 1,581 | 2.1 K to 1.6 K (-24.03 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 500 | 19,935 | 2,081 | 1.6 K to 2.1 K (+31.63 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 4,320 | 172,238 | 21,680 | |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 5,875 | 234,236 | 26,000 | |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 13,125 | 523,294 | 31,875 | |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.83 | 4,320 | 219,586 | 32,495 | 36.8 K to 32.5 K (-11.73 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 4,320 | 172,238 | 36,815 | 32.5 K to 36.8 K (+13.29 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.11 | 5,875 | 294,396 | 32,495 | 38.4 K to 32.5 K (-15.31 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 5,875 | 234,236 | 38,370 | 32.5 K to 38.4 K (+18.08 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.11 | 13,125 | 657,694 | 32,495 | 45.6 K to 32.5 K (-28.77 %) |
Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 13,125 | 523,294 | 45,620 | 32.5 K to 45.6 K (+40.39 %) |
Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 39.87 | 15,000 | 598,050 | 15,000 | |
Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Sell | S | 46.77 | 15,000 | 701,600 | 32,476 | 47.5 K to 32.5 K (-31.59 %) |
Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 39.87 | 15,000 | 598,050 | 47,476 | 32.5 K to 47.5 K (+46.19 %) |
Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 39.87 | 15,000 | 598,050 | 15,000 | |
Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Sell | S | 46.77 | 15,000 | 701,600 | 32,476 | 47.5 K to 32.5 K (-31.59 %) |
Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 39.87 | 15,000 | 598,050 | 47,476 | 32.5 K to 47.5 K (+46.19 %) |
Oct 22 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 46.86 | 2,889 | 135,386 | 13,794 | 16.7 K to 13.8 K (-17.32 %) |
Oct 19 2020 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 3,554 | |
Oct 19 2020 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Buy | M | 0.00 | 1,778 | 0 | 5,334 | 3.6 K to 5.3 K (+50.00 %) |
Oct 19 2020 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 3,554 | |
Oct 19 2020 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Buy | M | 0.00 | 1,778 | 0 | 5,334 | 3.6 K to 5.3 K (+50.00 %) |
Oct 14 2020 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 18.15 | 21,237,715 | 385,464,527 | 98,322,397 | 77.1 M to 98.3 M (+27.55 %) |
Sep 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.41 | 50,000 | 2,520,460 | 650,391 | 700.4 K to 650.4 K (-7.14 %) |
Sep 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.18 | 2,000 | 100,360 | 1,581 | 3.6 K to 1.6 K (-55.85 %) |
Sep 18 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 28.47 | 11,250 | 320,288 | 0 | |
Sep 18 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 12.94 | 11,250 | 145,575 | 0 | |
Sep 18 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 28.47 | 11,250 | 320,288 | 88,305 | 77.1 K to 88.3 K (+14.60 %) |
Sep 18 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 12.94 | 11,250 | 145,575 | 77,055 | 65.8 K to 77.1 K (+17.10 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | J | 44.46 | 121 | 5,379 | 32,495 | 32.4 K to 32.5 K (+0.37 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Buy | J | 44.46 | 169 | 7,513 | 21,178 | 21 K to 21.2 K (+0.80 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Buy | J | 44.46 | 1 | 44 | 30,447 | 30.4 K to 30.4 K (0.00 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Sell | S | 53.70 | 314 | 16,862 | 28,879 | 29.2 K to 28.9 K (-1.08 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | J | 44.46 | 236 | 10,491 | 29,193 | 29 K to 29.2 K (+0.82 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | J | 44.46 | 112 | 4,979 | 32,476 | 32.4 K to 32.5 K (+0.35 %) |
Sep 02 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Buy | J | 44.46 | 1 | 44 | 5,302 | 5.3 K to 5.3 K (+0.02 %) |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Buy | M | 0.00 | 1,778 | 0 | 3,556 | 1.8 K to 3.6 K (+100.00 %) |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Buy | M | 0.00 | 1,778 | 0 | 5,334 | 3.6 K to 5.3 K (+50.00 %) |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 667 | 0 | 17,308 | 16.6 K to 17.3 K (+4.01 %) |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 889 | 0 | 16,641 | 15.8 K to 16.6 K (+5.64 %) |
Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 1,778 | 0 | 15,752 | 14 K to 15.8 K (+12.72 %) |